The U.S. Food and Drug Administration has approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.
Independent chain Benzer Pharmacy has opened three new stores through its franchise model.
To address recommendations by the Advisory Committee on Immunization Practices, Sanofi Pasteur has increased production of Fluzone Quadrivalent vaccine where possible.
Pennsylvania Wolf’s signing of Senate Bill 514 has earned him praise from both the Biotechnology Innovation Organization (BIO) and Pennsylvania Bio.
Boothe had previously served as Perrigo’s EVP and general manager, where he was responsible for U.S. pharmaceuticals, including generics and specialty.
For the 12 months ended May 31, the product had U.S. sales of $6.7 billion.
Apotex has launched rosuvastatin calcium tablets, the generic equivalent of Crestor by AstraZeneca.
Teva Pharmaceuticals has added Sumatriptan Injection, USP (autoinjector) to its line of generic products.
Two new surveys conducted by the American Association of Clinical Endocrinologists reveal surprising and new information about adults living with type 2 diabetes.
Teva announced that its Octreotide Acetate Injection, 50 mcg/mL, is back in stock and ready to order.